#scleroderma Suchergebnisse
Congratulations to Dr. Zsuzsanna McMahan on her award from Promote Altruism! This is supporting her critical work in the field of the debilitating GI manifestations of #scleroderma . Thank you for all you do for your patients! #rheumatology
✨How can we better understand and treat fibrotic diseases? Meet Dr. Dinesh Khanna at #ECM2026. @sclerodermaUM He is a Professor of Medicine and Director of the University of Michigan (@UMich) Scleroderma Program , pioneering precision research in #scleroderma and #fibrosis.
Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.
Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma…
#scleroderma 1. why is SSc- a 'fibrotic disease' treated with immunosuppressive? 2. Why dont every patient with early SSc respond to immunosuppressive? the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity. @IRACON24Blr
🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma! 👏 Their work drives research & hope for the #Scleroderma community. 🎧 Listen to Voices from SSc – Ep.1 🔗 Register free: worldsclerofound.org/register/ #WSFAcademy #SSc #Research #ILD
Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma
#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]
Exploring the intersection of #Scleroderma and #GAVE — uncovering key demographic and mortality trends from a national inpatient analysis. Honored to share our findings at #ACR2025! #RheumResearch
2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!
Systemic Sclerosis–Associated ILD Watch Alicia Hinze, MD, share personalized strategies for managing Systemic Sclerosis–Associated ILD. Sponsored By: Boehringer Ingelheim buff.ly/w9qmEr7 #ILD #Scleroderma
👩⚕️ Tight, mask-like face? Think Scleroderma (Systemic Sclerosis) — not Sjögren’s or Lupus. Early recognition of skin tightening & Raynaud’s = better outcomes. #Rheumatology #MedTwitter #Scleroderma #GPs #RheumRounds @DrAkhilX @IhabFathiSulima @Janetbirdope
This clinical sign is mostly associated with which of the following condition? A) Sjögren syndrome B) Scleroderma C) Dermatomyositis D) Lupus
🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…
Happy Monday friends! #Scleroderma Awareness Month still! Busy week for me! @SusanLovesPinot @MaryannDonie @SnoozeGirl7 @angel80197423 @rosavil17613516 @soulsister420 @Irma_Spikeymama @medic2RN_RJC @PopPuffsPotAlot @GSmokesweed1 @Floor_model @KarenMOshaugh @Pville_Sandy
Delighted to present the @bmsnews data on #scleroderma #eular2025. Breakfree-1 data showing CAR-T is well tolerated with beneficial effects on skin and FVC and composite endpoint, the revised CRISS.
🆕#EULAR 2024 recommendations for treatment of #SystemicSclerosis #Scleroderma slide produced by @RheumNow #ILD #Raynauds #pulmonaryhypertension #DigitalUlcers
World experts in #scleroderma Drs. Bottini and Assassi met up to moderate an excellent session at #ACR25 !
Congratulations to Dr. Zsuzsanna McMahan on her award from Promote Altruism! This is supporting her critical work in the field of the debilitating GI manifestations of #scleroderma . Thank you for all you do for your patients! #rheumatology
``` 🚨 VEDOSS = EARLY #Scleroderma ✅ Must: Raynaud’s + ≥1 Red Flag 🔴 Puffy fingers → early swelling 🔴 +ve ANA (centromere/speckled) 🔴 Abnormal capillaroscopy 🔴 SSc antibodies (ACA, topo, RNA pol) ⚠️ ≥3 flags = 80–90% → SSc in 5 yrs Screen NOW! #scleroderma
✨How can we better understand and treat fibrotic diseases? Meet Dr. Dinesh Khanna at #ECM2026. @sclerodermaUM He is a Professor of Medicine and Director of the University of Michigan (@UMich) Scleroderma Program , pioneering precision research in #scleroderma and #fibrosis.
Primary Raynaud's is not correlated with any underlying medical condition, whereas secondary Raynaud's is causally connected to another medical condition, such as #scleroderma or #lupus. Read more, here: bit.ly/3bL8xkT #raynaudsphenomenon #frosties
#ACR25 Unlike other CTDs, #scleroderma -diagnosis a little bit later -few of patients (but not none) desire pregnancy this study show: Fetal and maternal outcomes in #systemicsclerosis pregnancies, are not big issue. This is promising for SSc acrabstracts.org/abstract/fetal…
🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma! 👏 Their work drives research & hope for the #Scleroderma community. 🎧 Listen to Voices from SSc – Ep.1 🔗 Register free: worldsclerofound.org/register/ #WSFAcademy #SSc #Research #ILD
Exploring the intersection of #Scleroderma and #GAVE — uncovering key demographic and mortality trends from a national inpatient analysis. Honored to share our findings at #ACR2025! #RheumResearch
UT Houston #Rheumatology division welcomes Dr. Jörg Distler who shared his incredible work regarding molecular profiling of fibroblasts in #scleroderma. Thank you for your insights and all of your efforts!
World experts in #scleroderma Drs. Bottini and Assassi met up to moderate an excellent session at #ACR25 !
A lot of enthusiasm about CAR-T therapy in #scleroderma. Data from Phase 1 trial sclerodermanews.com/news/car-t-cel…
Our article on localized #scleroderma is out in BJD. Thank you all coauthors! Localized scleroderma and related comorbidities: a single centre cohort study | British Journal of Dermatology | Oxford Academic academic.oup.com/bjd/advance-ar…
academic.oup.com
Localized scleroderma and related comorbidities: a single centre cohort study
This single-center cohort study examined 155 patients with localized scleroderma (morphea) in Southwest Finland, highlighting a predominance in females and
Primary Raynaud's is not correlated with any underlying medical condition, whereas secondary Raynaud's is causally connected to another medical condition, such as #scleroderma or #lupus. Read more, here: bit.ly/3bL8xkT #raynaudsphenomenon #frosties
#ACR25: Mary Alore, #Scleroderma patient and advocate, speaking Oct. 28 at the 2025 @ACRheum Convergence in Chicago about #CognitiveDysfunction or “brain fog” in #RheumaticDiseases. Image & quote taken by Senior Correspondent, @LLuxner #RareDisease #Rheumatology #BrainFog
Join us at clinical trial booth #972 at @ACRheum 2025 to learn more about the RESOLUTION trial, our investigational dual-targeted CD19/CD70 allogeneic CAR T for adults with #lupus, #myositis, and #scleroderma. $ALLO
Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.
Congratulations to Dr. Zsuzsanna McMahan on her award from Promote Altruism! This is supporting her critical work in the field of the debilitating GI manifestations of #scleroderma . Thank you for all you do for your patients! #rheumatology
🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma! 👏 Their work drives research & hope for the #Scleroderma community. 🎧 Listen to Voices from SSc – Ep.1 🔗 Register free: worldsclerofound.org/register/ #WSFAcademy #SSc #Research #ILD
Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
#scleroderma 1. why is SSc- a 'fibrotic disease' treated with immunosuppressive? 2. Why dont every patient with early SSc respond to immunosuppressive? the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity. @IRACON24Blr
Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma…
✨How can we better understand and treat fibrotic diseases? Meet Dr. Dinesh Khanna at #ECM2026. @sclerodermaUM He is a Professor of Medicine and Director of the University of Michigan (@UMich) Scleroderma Program , pioneering precision research in #scleroderma and #fibrosis.
#Calcinosis is tough to treat! Here’s a nice summary of options to consider in #Scleroderma & #DM including biologics (RTX in SSc and Tofacitinib in DM) and Minocycline 👉 Needs individualizing! Excellent talk by Dr. Valenzuela #ACR24 #ACRambassador #ReviewCourse @ACRheum
🆕#EULAR 2024 recommendations for treatment of #SystemicSclerosis #Scleroderma slide produced by @RheumNow #ILD #Raynauds #pulmonaryhypertension #DigitalUlcers
Dr. Aos Aboabat, #Scleroderma Clinical Research Fellow @SchroederInst, supervised by Dr. @SindhuJohnson5, presented his research at the Rheumatology Ogryzlo Research Day @UofT and will be graduating this year! #WorldSclerodermaDay
Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma
Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients! @CedarsSinaiMed
#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]
Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
🆕 @RheumatologyUK 2024 #SystemicSclerosis guidelines academic.oup.com/rheumatology/a… By Prof Chris Denton &Colleagues #scleroderma #PAH #ILD #Raynauds #arthritis
#Scleroderma mimics From Textbook Scleroderma From Pathogenesis to Comprehensive management. Chapter 11 (Hummers et Tyndall) 2024 👇 #Rheumatology #MedTwitter
#Scleroderma organ specific associated antibodies. #systemicsclerosis & Antibodies associated w/overlap SSc Extracted from Textbook Scleroderma From Pathogenesis to Comprehensive management 2024 #Rheumatology #MedTwitter 👇
Happy Monday friends! #Scleroderma Awareness Month still! Busy week for me! @SusanLovesPinot @MaryannDonie @SnoozeGirl7 @angel80197423 @rosavil17613516 @soulsister420 @Irma_Spikeymama @medic2RN_RJC @PopPuffsPotAlot @GSmokesweed1 @Floor_model @KarenMOshaugh @Pville_Sandy
🆕CD19 CAR T Cell treatment -A potentially promising future treatment in #SLE #scleroderma #myositis -Needs close collaboration with haematology Great explanation by @chriswincup #ACR24 #Lupus #SystemicSclerosis #IIM
Something went wrong.
Something went wrong.
United States Trends
- 1. Cam Coleman 3,218 posts
- 2. Vandy 5,162 posts
- 3. Iowa 29.3K posts
- 4. Auburn 13.9K posts
- 5. #AEWCollision 2,364 posts
- 6. Oregon 40K posts
- 7. #UFCVegas111 10.4K posts
- 8. Dante Moore 3,507 posts
- 9. Wisconsin 17.5K posts
- 10. Bauer Sharp N/A
- 11. Vanderbilt 3,927 posts
- 12. Indiana 42.9K posts
- 13. Heisman 12K posts
- 14. Penn State 26.1K posts
- 15. Mendoza 24.3K posts
- 16. Pavia 2,172 posts
- 17. #Svengoolie N/A
- 18. Badgers 3,725 posts
- 19. Jedd Fisch N/A
- 20. Bama 8,928 posts